Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
Open Access
- 20 May 2008
- journal article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 7 (1), 41
- https://doi.org/10.1186/1476-4598-7-41
Abstract
In high grade gliomas, 1p19q codeletion and EGFR amplification are mutually exclusive and predictive of dramatically different outcomes. We performed a microarray gene expression study of four high grade gliomas with 1p19q codeletion and nine with EGFR amplification, identified by CGH-array. The two groups of gliomas exhibited very different gene expression profiles and were consistently distinguished by unsupervised clustering analysis. One of the most striking differences was the expression of normal brain genes by oligodendrogliomas with 1p19q codeletion. These gliomas harbored a gene expression profile that partially resembled the gene expression of normal brain samples, whereas gliomas with EGFR amplification expressed many genes in common with glioblastoma cancer stem cells. The differences between the two types of gliomas and the expression of neuronal genes in gliomas with 1p19q codeletion were both validated in an independent series of 16 gliomas using real-time RT-PCR with a set of 22 genes differentiating the two groups of gliomas (AKR1C3, ATOH8, BMP2, C20orf42, CCNB1, CDK2, CHI3L1, CTTNBP2, DCX, EGFR, GALNT13, GBP1, IGFBP2, IQGAP1, L1CAM, NCAM1, NOG, OLIG2, PDPN, PLAT, POSTN, RNF135). Immunohistochemical study of the most differentially expressed neuronal gene, alpha-internexin, clearly differentiated the two groups of gliomas, with 1p19q codeletion gliomas showing specific staining in tumor cells. These findings provide evidence for neuronal differentiation in oligodendrogliomas with 1p19q codeletion and support the hypothesis that the cell of origin for gliomas with 1p19q codeletion could be a bi-potential progenitor cell, able to give rise to both neurons and oligodendrocytes.Keywords
This publication has 36 references indexed in Scilit:
- Ascl1 is required for oligodendrocyte development in the spinal cordDevelopment, 2008
- CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular ProfilesCancer Research, 2007
- The Proneural GeneMash1Specifies an Early Population of Telencephalic OligodendrocytesJournal of Neuroscience, 2007
- Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular targetProceedings of the National Academy of Sciences of the United States of America, 2006
- Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI featuresBrain, 2006
- Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiationAnnals of Neurology, 2006
- Gene Expression Profiles Associated with Treatment Response in OligodendrogliomasCancer Research, 2005
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPsGenes to Cells, 2005
- Math6, a bHLH gene expressed in the developing nervous system, regulates neuronal versus glial differentiationGenes to Cells, 2001